Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia

Journal of Clinical Investigation

Volumn 124, Issue 9, 2014, Pages 3767-3780

  Wang, David H ^a,b,c   Tiwari, Anjana ^b   Kim, Monica E ^b   Clemons, Nicholas J ^d,e   Regmi, Nanda L ^b   Hodges, William A ^b   Berman, David M ^f   Montgomery, Elizabeth A ^g   Watkins, D Neil ^h   Zhang, Xi ^b   Zhang, Qiuyang ^b   Jie, Chunfa ⁱ   Spechler, Stuart J ^a,b,c   Souza, Rhonda F ^a,b,c  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b Department of Internal Medicine   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f QUEEN S UNIVERSITY   (Canada)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; HEPATOCYTE NUCLEAR FACTOR 3BETA; MUCIN 2; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR SOX9; AGR2 PROTEIN, MOUSE; FOXA2 PROTEIN, MOUSE; GLI PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; MUC2 PROTEIN, MOUSE; MUCOPROTEIN; SOX9 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BARRETT ESOPHAGUS; BARRETT METAPLASIA; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; ESOPHAGUS; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; METAPLASIA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; ANIMAL; C57BL MOUSE; EMBRYOLOGY; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; BARRETT ESOPHAGUS; ESOPHAGUS; FEMALE; HEDGEHOG PROTEINS; HEPATOCYTE NUCLEAR FACTOR 3-BETA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MUCIN-2; MUCOPROTEINS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84907014877     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI66603     Document Type: Article

References (65)

1. Tosh D, Slack JM. How cells change their phenotype. Nat Rev Mol Cell Biol. 2002;3(3):187-194.
2. Walker MM. Is intestinal metaplasia of the stomach reversible? Gut. 2003;52(1):1-4.
3. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med. 1961;265:253-267.
4. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013;310(6):627-636.
5. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324-331.
6. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9(7):873-886.
7. Sandler RS, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122(5):1500-1511.
8. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19(6):1468-1470.
9. Chen H, Fang Y, Tevebaugh W, Orlando RC, Shaheen NJ, Chen X. Molecular mechanisms of Barrett's esophagus. Dig Dis Sci. 2011;56(12):3405-3420.
10. Yang A, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999;398(6729):714-718.
11. Daniely Y, et al. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol Cell Physiol. 2004;287(1):C171-C181.
12. Bass AJ, et al. SOX2 is an amplified lineagesurvival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet. 2009;41(11):1238-1242.
13. Long KB, Hornick JL. SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum Pathol. 2009;40(12):1768-1773.
14. Chan CW, et al. Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci U S A. 2009;106(6):1936-1941.
15. Wong NA, et al. CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A. 2005;102(21):7565-7570.
16. Huo X, et al. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology. 2010;139(1):194-203.
17. Gao N, White P, Kaestner KH. Establishment of intestinal identity and epithelial-mesenchymal signaling by Cdx2. Dev Cell. 2009;16(4):588-599.
18. Blache P, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004;166(1):37-47.
19. Wang DH, et al. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology. 2010;138(5):1810-1822.
20. Yang Q, Bermingham NA, Finegold MJ, Zoghbi HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science. 2001;294(5549):2155-2158.
21. Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol. 2001;32(11):1157-1165.
22. Chen X, et al. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers. BMC Gastroenterol. 2008;8:1.
23. Eda A, et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol. 2003;38(1):14-22.
24. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK. The histologic spectrum of Barrett's esophagus. N Engl J Med. 1976;295(9):476-480.
25. Hahn HP, et al. Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus. Am J Surg Pathol. 2009;33(7):1006-1015.
26. Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140(3):e18-e52.
27. Sasaki H, Hui C, Nakafuku M, Kondoh H. A binding site for Gli proteins is essential for HNF- 3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development. 1997;124(7):1313-1322.
28. Dufort D, Schwartz L, Harpal K, Rossant J. The transcription factor HNF3β is required in visceral endoderm for normal primitive streak morphogenesis. Development. 1998;125(16):3015-3025.
29. Ang SL, Rossant J. HNF-3β is essential for node and notochord formation in mouse development. Cell. 1994;78(4):561-574.
30. Pohler E, et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics. 2004;3(6):534-547.
31. Wang J, et al. Differential gene expression in normal esophagus and Barrett's esophagus. J Gastroenterol. 2009;44(9):897-911.
32. Hao Y, Triadafilopoulos G, Sahbaie P, Young HS, Omary MB, Lowe AW. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology. 2006;131(3):925-933.
33. Steininger H, Pfofe DA, Muller H, Haag-Sunjic G, Fratianu V. Expression of CDX2 and MUC2 in Barrett's mucosa. Pathol Res Pract. 2005; 201(8-9):573-577.
34. Yu WY, Slack JM, Tosh D. Conversion of columnar to stratified squamous epithelium in the developing mouse oesophagus. Dev Biol. 2005;284(1):157-170.
35. van der Sluis M, et al. Forkhead box transcription factors Foxa1 and Foxa2 are important regulators of Muc2 mucin expression in intestinal epithelial cells. Biochem Biophys Res Commun. 2008;369(4):1108-1113.
36. Ye DZ, Kaestner KH. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology. 2009;137(6):2052-2062.
37. Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns. 2004;5(2):193-208.
38. Litingtung Y, Lei L, Westphal H, Chiang C. Sonic hedgehog is essential to foregut development. Nat Genet. 1998;20(1):58-61.
39. Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC. Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet. 1998;20(1):54-57.
40. Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A. 2007;104(25):10500-10505.
41. Barrionuevo F, et al. Homozygous inactivation of Sox9 causes complete XY sex reversal in mice. Biol Reprod. 2006;74(1):195-201.
42. Harfe BD, Scherz PJ, Nissim S, Tian H, McMahon AP, Tabin CJ. Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell. 2004;118(4):517-528.
43. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16(21):2813-2828.
44. Chiang C, et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature. 1996;383(6599):407-413.
45. Wan H, et al. Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J Biol Chem. 2005;280(14):13809-13816.
46. Jaiswal KR, et al. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis Esophagus. 2007;20(3):256-264.
47. Bajpai M, Liu J, Geng X, Souza RF, Amenta PS, Das KM. Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest. 2008;88(6):643-651.
48. Taipale J, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature. 2000;406(6799):1005-1009.
49. Park SW, et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci U S A. 2009;106(17):6950-6955.
50. Zhao F, et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice. Dev Biol. 2010;338(2):270-279.
51. Sharma SK, et al. Characterization of a novel Foxa (hepatocyte nuclear factor-3) site in the glucagon promoter that is conserved between rodents and humans. Biochem J. 2005;389(pt 3):831-841.
52. Watts JA, et al. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development. PLoS Genet. 2011;7(9):e1002277.
53. Wang X, et al. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell. 2011;145(7):1023-1035.
54. Quante M, et al. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of barrett-like metaplasia. Cancer Cell. 2012;21(1):36-51.
55. Shen CN, Burke ZD, Tosh D. Transdifferentiation, metaplasia and tissue regeneration. Organogenesis. 2004;1(2):36-44.
56. Zhang HY, et al. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol. 2008;295(3):G470-G478.
57. Souza RF, et al. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus. Am J Gastroenterol. 2005;100(3):551-559.
58. Menke V, et al. Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by gamma-secretase inhibition. Dis Model Mech. 2010;3(1-2):104-110.
59. Que J, et al. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development. 2007;134(13):2521-2531.
60. Rodriguez P, Da Silva S, Oxburgh L, Wang F, Hogan BL, Que J. BMP signaling in the development of the mouse esophagus and forestomach. Development. 2010;137(24):4171-4176.
61. Tamagawa Y, et al. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. Lab Invest. 2012;92(6):896-909.
62. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21(1):70-71.
63. Briggs KJ, et al. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes Dev. 2008;22(6):770-785.
64. Newton MA, Kendziorski CM, Richmond CS, Blattner FR, Tsui KW. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001;8(1):37-52.
65. Newton MA, Kendziorski CM. Parametric empirical Bayes methods for microarrays. In: Parmigiani G, Garrett ES, Irizarry R, Zeger SL, eds. The Analysis Of Gene Expression Data: Methods And Software. New York, New York, USA: Springer Verlag; 2003:254-271.